Sibannac Formulate LOI To Acquire SPUR Biotech
Sibannac, Inc. (OTC Pink: SNNC) officialized yesterday in a press release, an intent in acquiring SPUR Biotech, LLC, an Ohio-based developer of plant-based vaccines. Spur is already an existing marketing client […]